A detailed history of World Equity Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, World Equity Group, Inc. holds 5,058 shares of ABT stock, worth $590,774. This represents 0.21% of its overall portfolio holdings.

Number of Shares
5,058
Previous 5,004 1.08%
Holding current value
$590,774
Previous $520 Million 10.92%
% of portfolio
0.21%
Previous 0.16%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$100.07 - $118.13 $5,403 - $6,379
54 Added 1.08%
5,058 $577 Million
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $501,635 - $559,951
-4,980 Reduced 49.88%
5,004 $520 Million
Q1 2024

Jul 18, 2024

BUY
$109.52 - $120.96 $1.09 Million - $1.21 Million
9,984 New
9,984 $1.13 Billion
Q4 2023

Jul 22, 2024

SELL
$90.19 - $110.4 $50,145 - $61,382
-556 Reduced 6.49%
8,008 $881 Million
Q3 2023

Jul 22, 2024

BUY
$95.53 - $114.62 $340,086 - $408,047
3,560 Added 71.14%
8,564 $829 Million
Q2 2023

Aug 26, 2024

SELL
$100.78 - $112.29 $2.04 Million - $2.28 Million
-20,268 Reduced 81.47%
4,611 $503 Million
Q1 2023

Aug 26, 2024

BUY
$96.86 - $114.01 $1.93 Million - $2.27 Million
19,875 Added 397.18%
24,879 $444 Million
Q4 2022

Sep 06, 2024

SELL
$95.06 - $111.52 $27,282 - $32,006
-287 Reduced 4.88%
5,595 $614 Million
Q3 2022

Sep 06, 2024

BUY
$96.76 - $112.03 $84,955 - $98,362
878 Added 17.55%
5,882 $569 Million
Q2 2022

Sep 06, 2024

SELL
$102.07 - $123.37 $37,051 - $44,783
-363 Reduced 5.94%
5,747 $624 Million
Q1 2022

Sep 06, 2024

BUY
$114.02 - $139.04 $126,106 - $153,778
1,106 Added 22.1%
6,110 $723 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track World Equity Group, Inc. Portfolio

Follow World Equity Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on World Equity Group, Inc. with notifications on news.